Ardelyx to be Acquired by Advent International for $1.00/Share
Ticker: ARDX · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1437402
| Field | Detail |
|---|---|
| Company | Ardelyx, Inc. (ARDX) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | medium |
| Sentiment | bullish |
Sentiment: bullish
Topics: acquisition, merger, private-equity
Related Tickers: ARDX
TL;DR
Ardelyx is getting bought out by Advent International for $1/share cash, deal expected Q3.
AI Summary
Ardelyx, Inc. announced on June 18, 2025, that it has entered into a definitive agreement to be acquired by a subsidiary of Advent International Corporation for $1.00 per share in cash, representing an approximate 39% premium over the closing price on June 17, 2025. The transaction is expected to close in the third quarter of 2025, subject to customary closing conditions.
Why It Matters
This acquisition by a private equity firm could lead to significant changes for Ardelyx's operations and its drug development pipeline, potentially impacting its future as a publicly traded entity.
Risk Assessment
Risk Level: medium — The acquisition price represents a premium, but the deal is subject to closing conditions and regulatory approvals, which could introduce uncertainty.
Key Numbers
- $1.00 — Acquisition Price Per Share (Cash consideration offered to Ardelyx shareholders.)
- 39% — Premium (Percentage increase over the previous day's closing price.)
Key Players & Entities
- Ardelyx, Inc. (company) — Company filing the 8-K and subject of the acquisition.
- Advent International Corporation (company) — Acquiring entity.
- $1.00 (dollar_amount) — Per share acquisition price.
- June 18, 2025 (date) — Date of the 8-K filing and announcement.
- June 17, 2025 (date) — Date used for calculating the premium.
- third quarter of 2025 (date) — Expected closing period for the acquisition.
FAQ
What is the total value of the acquisition?
The filing does not explicitly state the total value of the acquisition, but it is based on $1.00 per share in cash for all outstanding shares of Ardelyx.
Who is acquiring Ardelyx?
Ardelyx is being acquired by a subsidiary of Advent International Corporation.
When is the acquisition expected to close?
The transaction is expected to close in the third quarter of 2025.
What is the premium offered for Ardelyx shares?
The acquisition represents an approximate 39% premium over Ardelyx's closing stock price on June 17, 2025.
Are there any specific conditions for the acquisition to close?
Yes, the transaction is subject to customary closing conditions.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding ARDELYX, INC. (ARDX).